How to measure hazards/risks following exposures to nanoscale or pigment-grade titanium dioxide particles.

Due to its multifunctional applications, titanium dioxide particles have widespread use in commerce. The particle-types function as sources of pigment color, in food products, anti-bacterial components, ultraviolet radiation scavengers, catalysts, as well as in cosmetics. Because of its inherent properties in a diverse number of products, exposures may occur via any of the major point-of-entry routes, i.e., inhalation, oral or dermal. Although the majority of TiO2 applications are known to exist in the pigment-grade form, nanoscale forms of TiO2 are also common components in several products. This brief review is designed to identify relevant toxicology and risk-related issues which inform health effects assessments on the various forms of titanium dioxide particles. While there has been an abundance of hazard data generated on titanium dioxide particulates, many of the published reports have limited informational value for assessing health effects due, in large part, to shortcomings in experimental design issues, such as: (1) inadequate material characterization of test samples; (2) questionable relevance of experimental systems employed to simulate human exposures; (3) applications of generally high doses, exclusive focus on acute toxicity endpoints, and a lack of reference benchmark control materials, to afford interpretation of measured results; and/or (4) failure to recognize fundamental differences between hazard and risk concepts. Accordingly, a number of important toxicology issues are identified and integrated herein to provide a more comprehensive assessment of the health risks of different forms of pigment-grade and nanoscale titanium dioxide particles. It is important to note that particle-types of different TiO2 compositions may have variable toxicity potencies, depending upon crystal structure, particle size, particle surface characteristics and surface coatings. In order to develop a more robust health risk evaluation of TiO2 particle exposures, this review focuses on the following issues: (1) Introduction to TiO2 particle chemistry/functionality and importance of robust material characterization of test samples; (2) Implementation of meaningful hazard studies for gauging EHS safety issues – pulmonary bioassay data and development of the Nano Risk Framework for developmental nano TiO2 compounds; (3) Epidemiological study findings on titanium dioxide workers – the most heavily-exposed populations; (4) Methodologies for setting occupational exposure limits including benchmarking or bridging comparisons; and (5) The importance of particle overload data in the lungs of rats as it relates to gauging the relevance of health effects for humans. A comprehensive evaluation of the existing animal and human health data is a necessary prerequisite for facilitating accurate assessments of human health risks to TiO2 exposures.

[1]  J. Everitt,et al.  Pulmonary responses of mice, rats, and hamsters to subchronic inhalation of ultrafine titanium dioxide particles. , 2004, Toxicological sciences : an official journal of the Society of Toxicology.

[2]  D. Warheit,et al.  Pulmonary exposures to Sepiolite nanoclay particulates in rats: resolution following multinucleate giant cell formation. , 2010, Toxicology letters.

[3]  Robert Gelein,et al.  A Comparative Dose-Related Response of Several Key Pro- and Antiinflammatory Mediators in the Lungs of Rats, Mice, and Hamsters After Subchronic Inhalation of Carbon Black , 2006, Journal of occupational and environmental medicine.

[4]  F. Hahn,et al.  Influence of exposure concentration or dose on the distribution of particulate material in rat and human lungs. , 2001, Environmental health perspectives.

[5]  J. Braun Titanium dioxide : A review , 1997 .

[6]  E. Ellis,et al.  Occupational exposure and mortality among workers at three titanium dioxide plants. , 2013, American journal of industrial medicine.

[7]  Stephen S. Olin,et al.  THE RELEVANCE OF THE RAT LUNG RESPONSE TO PARTICLE OVERLOAD FOR HUMAN RISK ASSESSMENT: A Workshop Consensus Report , 2000, Inhalation toxicology.

[8]  Robert Gelein,et al.  Effects of subchronically inhaled carbon black in three species. I. Retention kinetics, lung inflammation, and histopathology. , 2005, Toxicological sciences : an official journal of the Society of Toxicology.

[9]  Wolfgang Koch,et al.  Chronic Inhalation Exposure of Wistar Rats and two Different Strains of Mice to Diesel Engine Exhaust, Carbon Black, and Titanium Dioxide , 1995 .

[10]  Joseph K McLaughlin,et al.  A Cohort Mortality Study among Titanium Dioxide Manufacturing Workers in the United States , 2003, Journal of occupational and environmental medicine.

[11]  L. Pylkkänen,et al.  Inhalation exposure to nanosized and fine TiO2 particles inhibits features of allergic asthma in a murine model , 2010, Particle and Fibre Toxicology.

[12]  Julie W. Fitzpatrick,et al.  Principles for characterizing the potential human health effects from exposure to nanomaterials: elements of a screening strategy , 2005, Particle and Fibre Toxicology.

[13]  David B Warheit,et al.  How meaningful are the results of nanotoxicity studies in the absence of adequate material characterization? , 2008, Toxicological sciences : an official journal of the Society of Toxicology.

[14]  Leonard S. Levy,et al.  Review : The 'Particle Overload' Phenomenon and Human Risk Assessment , 1995 .

[15]  J. Siemiatycki,et al.  Exposure to titanium dioxide and risk of lung cancer in a population-based study from Montreal. , 2001, Scandinavian journal of work, environment & health.

[16]  Jack Siemiatycki,et al.  Risk Factors For Cancer In The Workplace , 1991 .

[17]  B. Brunekreef,et al.  IMMUNE BIOMARKERS IN RELATION TO EXPOSURE TO PARTICULATE MATTER: A Cross-Sectional Survey in 17 Cities of Central Europe , 2000, Inhalation toxicology.

[18]  J. Siemiatycki,et al.  Risk of lung cancer following exposure to carbon black, titanium dioxide and talc: Results from two case–control studies in Montreal , 2008, International journal of cancer.

[19]  David B Warheit,et al.  Long-term pulmonary responses of three laboratory rodent species to subchronic inhalation of pigmentary titanium dioxide particles. , 2002, Toxicological sciences : an official journal of the Society of Toxicology.

[20]  J. Mauderly,et al.  Lung Tissue Responses and Sites of Particle Retention Differ between Rats and Cynomolgus Monkeys Exposed Chronically to Diesel Exhaust and Coal Dust , 1997 .

[21]  W. Fayerweather,et al.  Epidemiologic study of workers exposed to titanium dioxide. , 1988, Journal of occupational medicine. : official publication of the Industrial Medical Association.

[22]  J. Siemiatycki,et al.  Risk of lung cancer following nonmalignant respiratory conditions: evidence from two case-control studies in Montreal, Canada. , 2006, Lung cancer.

[23]  Joyce Phillips,et al.  Mortality Among Titanium Dioxide Workers at Three DuPont Plants , 2010, Journal of occupational and environmental medicine.

[24]  Andrew Williams,et al.  Environmental and Molecular Mutagenesis 52:425^439 (2011) Research Article Pulmonary Response to Surface-Coated Nanotitanium Dioxide Particles Includes Induction of Acute Phase Response Genes, Inflammatory Cascades, and Changes in MicroRNAs: A Toxicogenom , 2022 .

[25]  Dario Mirabelli,et al.  Mortality Among Workers Employed in the Titanium Dioxide Production Industry in Europe , 2004, Cancer Causes & Control.

[26]  David B Warheit,et al.  Pulmonary instillation studies with nanoscale TiO2 rods and dots in rats: toxicity is not dependent upon particle size and surface area. , 2006, Toxicological sciences : an official journal of the Society of Toxicology.

[27]  Robert A Hoke,et al.  Development of a base set of toxicity tests using ultrafine TiO2 particles as a component of nanoparticle risk management. , 2007, Toxicology letters.

[28]  Kurt Straif,et al.  Carcinogenicity of carbon black, titanium dioxide, and talc. , 2006, The Lancet. Oncology.

[29]  K. P. Lee,et al.  Pulmonary response of rats exposed to titanium dioxide (TiO2) by inhalation for two years. , 1985, Toxicology and applied pharmacology.

[30]  D. Warheit,et al.  Inhalation of high concentrations of low toxicity dusts in rats results in impaired pulmonary clearance mechanisms and persistent inflammation. , 1997, Toxicology and applied pharmacology.

[31]  T. Webb,et al.  Pulmonary toxicity study in rats with three forms of ultrafine-TiO2 particles: differential responses related to surface properties. , 2007, Toxicology.